CAS: 308831-61-0 - N-[4-[1-[(2,6-Difluorophenyl)methyl]-1,2,3,4-tetrahydro-5-[[methyl(phenylmethyl)amino]methyl]-2,4-dioxo-3-phenylthieno[2,3-d]pyrimidin-6-yl]phenyl]-N′-methoxyurea

Fórmula: C₃₆H₃₁F₂N₅O₄S

InChI: InChI=1S/C36H31F2N5O4S/c1-41(20-23-10-5-3-6-11-23)21-28-31-33(44)43(26-12-7-4-8-13-26)36(46)42(22-27-29(37)14-9-15-30(27)38)34(31)48-32(28)24-16-18-25(19-17-24)39-35(45)40-47-2/h3-19H,20-22H2,1-2H3,(H2,39,40,45)

Clave InChI: InChIKey=UCQSBGOFELXYIN-UHFFFAOYSA-N

SMILES: O=C(NOC)NC=1C=CC(=CC1)C=2SC3=C(C(=O)N(C=4C=CC=CC4)C(=O)N3CC=5C(F)=CC=CC5F)C2CN(C)CC=6C=CC=CC6

Sinónimos:

• 1-{4-[5-{[Benzyl(Methyl)Amino]Methyl}-1-(2,6-Difluorobenzyl)-2,4-Dioxo-3-Phenyl-1,2,3,4-Tetrahydrothieno[2,3-D]Pyrimidin-6-Yl]Phenyl}-3-Methoxyurea
• 5-(N-Benzyl-N-methylaminomethyl)-1-(2,6-difluorobenzyl)-6-[4-(3-methoxyureido)phenyl]-3-phenylthieno[2,3-d]pyrimidine-2,4(1H,3H)dione
• N-[4-[1-[(2,6-Difluorophenyl)methyl]-1,2,3,4-tetrahydro-5-[[methyl(phenylmethyl)amino]methyl]-2,4-dioxo-3-phenylthieno[2,3-d]pyrimidin-6-yl]phenyl]-N′-methoxyurea
• Sufugolix
• Tak-013
• Urea, N-[4-[1-[(2,6-difluorophenyl)methyl]-1,2,3,4-tetrahydro-5-[[methyl(phenylmethyl)amino]methyl]-2,4-dioxo-3-phenylthieno[2,3-d]pyrimidin-6-yl]phenyl]-N′-methoxy-

Sufugolix

CAS: 308831-61-0

Sufugolix (TAK-013) is a potent and orally available luteinizing hormone-releasing hormone LHRH receptor.

• Fórmula: C₃₆H₃₁F₂N₅O₄S
• Pureza: 95.06%
• Forma y color: Solid
• Peso molecular: 667.72

1-[4-[1-[(2,6-Difluorophenyl)Methyl]-5-[(Methyl-(Phenylmethyl)Amino)Methyl]-2,4-Dioxo-3-Phenylthieno[4,5-e]Pyrimidin-6-Yl]Phenyl]-3- Methoxyurea

CAS: 308831-61-0

(3-Methoxy-1-[4-[1-[(2,6-difluorophenyl)methyl]-5-[(methyl-(phenylmethyl)amino)methyl]-2,4-dioxo-3-phenylthieno[4,5-e]pyrimidin-6-yl]phenyl]urea) is a potential drug for the treatment of prostate cancer. This agent has been …

• Fórmula: C₃₆H₃₁F₂N₅O₄S
• Pureza: Min. 95%
• Peso molecular: 667.73 g/mol